The effects of emicizumab on in vitro coagulation and fibrinolysis parameters in patients with disseminated intravascular coagulation with and without addition of anti-FVIII antibody.
Tomoko OnishiHanako ShimoSuguru HaradaKeiji NogamiPublished in: Haemophilia : the official journal of the World Federation of Hemophilia (2024)
The presence of Emi in the HA-model DIC plasma improved coagulation potentials, but did not increase coagulation potentials beyond those of DIC plasma in non-HA states.
Keyphrases